Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Genitourinary 1

Conditions

Melanoma 19Neuroblastoma 16Leukemia 15Prostatic Neoplasms 14Lymphoma 12Multiple Myeloma 10Breast Neoplasms 10Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Acute 8Leukemia, Lymphocytic, Chronic, B-Cell 8Glioblastoma 8Neoplasm Metastasis 6Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Fallopian Tube Neoplasms 6Neoplasms 5Hodgkin Disease 5Carcinoma, Non-Small-Cell Lung 5Uveal Melanoma 4Recurrence 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Kidney Neoplasms 4Glioma 4Carcinoma, Renal Cell 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms, Male 4Ovarian Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3

Interventions

Filgrastim 10Cyclophosphamide 8Granulocyte Colony-Stimulating Factor 6Melphalan 5Busulfan 5Vincristine 4Topotecan 4Temozolomide 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Ifosfamide 4Etoposide 4Thiotepa 3Radiotherapy 3Mesna 3Itraconazole 3Doxorubicin 3Cisplatin 3Carboplatin 3sargramostim 2fludarabine 2Therapeutics 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Drug Therapy 2Bone Marrow Transplantation 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Wilms Tumor × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT04040231 2025-05-13

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
10 enrolled
GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡